Group 1 - The company announced a price adjustment for the exchangeable bonds issued by its controlling shareholder, Heilongjiang Chuangda Group Co., Ltd. [1][2] - The first phase of the exchangeable bonds, with a total issuance of 910 million yuan and a term of 3 years, was completed on April 11, 2023 [1] - The second phase of the exchangeable bonds, with a total issuance of 90 million yuan and a term of 3 years, was completed on June 28, 2023 [2] Group 2 - The company’s 2024 profit distribution plan includes a cash dividend of 1.50 yuan per 10 shares, totaling approximately 141.13 million yuan [3] - The adjusted cash dividend per share, after considering the total share capital dilution, will be 0.15 yuan per share [3] - The record date for the profit distribution is set for August 19, 2025, with the ex-dividend date and cash dividend payment date on August 20, 2025 [3] Group 3 - The adjustment of the exchange price for the bonds is based on the company's profit distribution and follows specific formulas outlined in the bond issuance prospectus [4][5] - The exchange price for the first phase bond will be adjusted from 13.50 yuan to 13.35 yuan per share, while the second phase bond will be adjusted from 10.69 yuan to 10.54 yuan per share [5] - The controlling shareholder has sufficient stock available for the exchange after the price adjustments [5]
黑龙江珍宝岛药业股份有限公司关于控股股东非公开发行可交换公司债券换股价格调整的提示性公告